Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more!Diabetes Core UpdateWelcome to the latest episode (August 2026) of DOC Updates, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease...85 days agoImpact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more!Diabetes Core Update0:00 / 0:00Read the original at diabetescoreupdate.libsyn.comUse this feed in your RSS readerCopy the publisher’s public feed URL, or build an OPML reading list for another reader.Copy RSS URL Open RSS feed · Find feeds & export OPMLKeep up with this sourceFollow this sourceKeep this source in your dashboard and return to its latest articles. Email alerts are managed separately in Settings.FetchFeeds groups articles by feed so you can follow sources, compare coverage, and save stories for later.Back to all articles from Diabetes Core UpdateMore from this feedChoose another story from Diabetes Core Update.Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!Special Edition: Hypertension Part I—Overview and ManagementSpecial Edition: Highlights from the ADA's 2026 Scientific SessionsSpecial Edition: Lp(a) & CV RiskSpecial Edition: What's Next—Once-Weekly Insulins—Mechanisms and Practical ConsiderationsSpecial Edition: What's Next—CKD in Type 1 Diabetes—An Urgent Need for TherapiesEfficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!Special Edition: What's Next—Oral GLP-1 Receptor Agonists